NCT05117060 - Efficacy and Safety of LEO 152020 Tablets for the Treatment of Adults With Moderate to Severe Atopic Dermatitis | Biotech Hunter

Enrollment

216

Participants

Timeline

Start Date

December 13, 2021

Primary Completion Date

July 20, 2023

Study Completion Date

July 26, 2023

Conditions

Atopic Dermatitis

Interventions

DRUG

LEO 152020 tablet

LEO 152020 is a small drug molecule which can bind to the histamine 4 receptor (H4R) and prevent histamine from binding to the receptor. LEO 152020 is a tablet for oral administration.

DRUG

LEO 152020 placebo tablet

LEO 152020 placebo tablet contains the same excipients in the same concentration as LEO 152020 tablet, except that it does not contain the medical ingredient LEO 152020. LEO 152020 placebo is a tablet for oral administration.

Trial Locations (45)

2010

LEO Pharma Investigational Site, Darlinghurst

LEO Pharma Investigational Site, Sydney

2217

LEO Pharma Investigational Site, Kogarah

3053

LEO Pharma Investigational Site, Carlton

3168

LEO Pharma Investigational Site, Clayton

4102

LEO Pharma Investigational Site, Woolloongabba

10789

LEO Pharma Investigational Site, Berlin

14004

LEO Pharma Investigational Site, Córdoba

28046

LEO Pharma Investigational Site, Madrid

30625

LEO Pharma Investigational Site, Hanover

36001

LEO Pharma Investigational Site, Pontevedra

37130

LEO Pharma Investigational Site, Murfreesboro

39120

LEO Pharma Investigational Site, Magdeburg

45219

LEO Pharma Investigational Site, Cincinnati

48455

LEO Pharma Investigational Site, Bad Bentheim

66663

LEO Pharma Investigational Site, Merzig

75034

LEO Pharma Investigational Site, Frisco

90045

LEO Pharma Investigational Site, Los Angeles

90212

LEO Pharma Investigational Site, Beverly Hills

92123

LEO Pharma Investigational Site, San Diego

T2J 7E1

LEO Pharma Investigational Site, Calgary

T3E 0B2

LEO Pharma Investigational Site, Calgary

T5J 3S9

LEO Pharma Investigational Site, Edmonton

L3P 1X3

LEO Pharma Investigational Site, Markham

L4Y 4C5

LEO Pharma Investigational Site, Mississauga

L2H 1H5

LEO Pharma Investigational Site, Niagara Falls

G1V 4X7

LEO Pharma Investigational site, Québec

J7Z 7E2

LEO Pharma Investigational Site, Saint-Jérôme

360 01

LEO Pharma Investigational Site, Karlovy Vary

284 01

LEO Pharma Investigational Site, Kutná Hora

741 01

LEO Pharma Investigational Site, Nový Jičín

708 52

LEO Pharma Investigational Site, Ostrava-Poruba

100 34

LEO Pharma Investigational Site, Prague

812-8582

LEO Pharma Investigational Site, Fukuoka

811-3217

LEO Pharma Investigational Site, Fukutsu-shi

861-4101

LEO Pharma Investigational Site, Kumamoto

569-0824

LEO Pharma Investigational Site, Takatsuki-shi

136-0074

LEO Pharma Investigational Site, Koto-ku

108-0014

LEO Pharma Investigational Site, Minato-ku

30-033

LEO Pharma Investigational Site, Krakow

90-436

LEO Pharma Investigational Site, Lodz

20-081

LEO Pharma Investigational Site, Lublin

43-190

LEO Pharma Investigational Site, Mikołów

51-124

LEO Pharma Investigational Site, Wroclaw

51-685

LEO Pharma Investigational Site, Wroclaw